Broadwater Capital’s Edwards Lifesciences EW Stock Holding History

Broadwater Capital’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$104K	Hold	1,200	–	–	0.07%	83
2026 Q2	$109K	Hold	1,200	–	–	0.08%	85
2026 Q1	$102K	Hold	1,200	–	–	0.08%	85
2025 Q4	$102K	Hold	1,200	–	–	0.08%	85
2025 Q3	$93.3K	Sell	1,200 -720	-38%	-$56.3K	0.07%	94
2025 Q2	$150K	Hold	1,920	–	–	0.12%	81
2025 Q1	$139K	Hold	1,920	–	–	0.11%	84
2024 Q4	$142K	Hold	1,920	–	–	0.11%	83
2024 Q3	$127K	Hold	1,920	–	–	0.09%	87
2024 Q2	$177K	Hold	1,920	–	–	0.14%	80
2024 Q1	$183K	Hold	1,920	–	–	0.14%	82
2023 Q4	$146K	Buy	+1,920	New	+$134K	0.11%	89

Other funds holding EW

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM

JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $45.5B AUM 15.2% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $234B AUM 43.58% 1-Year Est. Return

Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

Broadwater Capital's EW Position: Q3 2026 in Review

Broadwater Capital held its Edwards Lifesciences (EW) position steady in Q3 2026 at 1,200 shares worth $104K. The position accounts for 0.07% of the portfolio, ranked #83.

Broadwater Capital first reported a position in EW in Q4 2023 and has held it in 12 quarters since. The position peaked at $183K in Q1 2024. 1,141 funds tracked by Wall St. Rank hold EW as of Q3 2026.

Broadwater Capital held 1,200 shares of Edwards Lifesciences worth $104K as of Q3 2026.
Broadwater Capital left its Edwards Lifesciences share count unchanged in Q3 2026.
Edwards Lifesciences made up 0.07% of Broadwater Capital's portfolio in Q3 2026, its #83 holding.
Broadwater Capital first reported a position in Edwards Lifesciences in Q4 2023 and has held it in 12 quarters since.
Broadwater Capital's Edwards Lifesciences position peaked at $183K in Q1 2024.
1,141 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2026.

Based on Broadwater Capital's 13F filing for Q3 2026, filed 12 Nov 2026.